Piritrexim
Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.
Product Specifications
CAS Number
72732-56-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
325.37
Molecular Formula
C17H19N5O2
Notes
Research use only, not for human use.
Receptor
DHFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1257897-01 0.02 mg (E-Coli)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details MBS1257897-02 0.02 mg (Yeast)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details MBS1257897-03 0.1 mg (E-Coli)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details MBS1257897-04 0.1 mg (Yeast)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details 
MBS1257897-05 0.02 mg (Baculovirus)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details 
MBS1257897-06 0.02 mg (Mammalian-Cell)
Recombinant Prochlorococcus marinus UPF0176 protein NATL1_14861 (NATL1_14861)
Ask
View Details